Spyre Therapeutics
Joshua R Friedman is currently working as the Senior Vice President at Spyre Therapeutics. Prior to this role, he held positions at Spark Therapeutics, Inc., Alnylam Pharmaceuticals, and The Janssen Pharmaceutical Companies of Johnson & Johnson. He also served as an Associate Professor and Assistant Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. Joshua holds a Doctor of Medicine (MD) in Medicine, a PhD in Cell/Cellular and Molecular Biology, and a Bachelor's Degree in Biochemistry from Harvard University.
Spyre Therapeutics
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.